These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 10377185)

  • 1. Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.
    Heinzel FP; Rerko RM
    J Exp Med; 1999 Jun; 189(12):1895-906. PubMed ID: 10377185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
    Heinzel FP; Maier RA
    Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.
    Nabors GS; Farrell JP
    Infect Immun; 1994 Dec; 62(12):5498-504. PubMed ID: 7960131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
    Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
    Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
    Sadick MD; Heinzel FP; Holaday BJ; Pu RT; Dawkins RS; Locksley RM
    J Exp Med; 1990 Jan; 171(1):115-27. PubMed ID: 2104918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection.
    Kropf P; Herath S; Klemenz R; Müller I
    Infect Immun; 2003 Apr; 71(4):1961-71. PubMed ID: 12654814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice.
    Hondowicz BD; Park AY; Elloso MM; Scott P
    Eur J Immunol; 2000 Jul; 30(7):2007-14. PubMed ID: 10940890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection.
    Mohrs M; Holscher C; Brombacher F
    Infect Immun; 2000 Apr; 68(4):1773-80. PubMed ID: 10722563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice.
    Uzonna JE; Bretscher PA
    Eur J Immunol; 2001 Nov; 31(11):3175-84. PubMed ID: 11745334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different cytokines are required for induction and maintenance of the Th2 type response in DBA/2 mice resistant to infection with Leishmania major.
    Nashed BF; Maekawa Y; Takashima M; Zhang T; Ishii K; Dainichi T; Ishikawa H; Sakai T; Hisaeda H; Himeno K
    Microbes Infect; 2000 Oct; 2(12):1435-43. PubMed ID: 11099930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.
    Holaday BJ; Sadick MD; Wang ZE; Reiner SL; Heinzel FP; Parslow TG; Locksley RM
    J Immunol; 1991 Sep; 147(5):1653-8. PubMed ID: 1831830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells.
    Hoshino T; Yagita H; Ortaldo JR; Wiltrout RH; Young HA
    Eur J Immunol; 2000 Jul; 30(7):1998-2006. PubMed ID: 10940889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute IL-4 Governs Pathogenic T Cell Responses during
    Poudel B; Yorek MS; Mazgaeen L; Brown SA; Kanneganti TD; Gurung P
    Immunohorizons; 2020 Sep; 4(9):546-560. PubMed ID: 32948646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.